American Journal of Kidney Diseases

Heart Failure With Preserved or Reduced Ejection Fraction in Patients Treated With Peritoneal Dialysis

Published:March 08, 2013DOI:


      Heart failure is one of the most frequent complications in dialysis patients. However, little is known of the significance of the entity “heart failure with preserved ejection fraction” (HFPEF) in this population. This study aimed to determine the prevalence, clinical profiles, and long-term outcomes of peritoneal dialysis patients with HFPEF.

      Study Design

      Prospective cohort study.

      Setting & Participants

      220 patients treated with peritoneal dialysis were recruited from a university teaching hospital in Hong Kong.


      Heart failure was defined clinically based on the presence of: (1) symptoms and signs, including dyspnea, increased jugular venous pressure, and basal crepitations; (2) radiographic evidence of pulmonary venous congestion or interstitial edema; and (3) resolution of symptoms, signs, and radiographic changes with hypertonic peritoneal dialysis exchanges. Based on a combination of clinical history of heart failure and echocardiography-derived ejection fraction, patients were classified as having no heart failure, HFPEF, and heart failure with reduced ejection fraction (HFREF).


      All-cause mortality, cardiac death, heart failure, and fatal or nonfatal cardiovascular events.


      All patients underwent 2-dimensional echocardiography and tissue Doppler imaging at baseline and were followed up prospectively for clinical events for 4 years.


      86 (39%) patients had heart failure, of whom 54.7% had preserved ejection fraction ≥50% and 45.3% had reduced ejection fraction <50%. Patients with HFPEF were intermediate between those with no heart failure and those with HFREF in terms of blood pressure, prevalence of coronary artery disease, diabetes, cardiac biomarkers, left ventricular mass, volume, and ratio of early mitral inflow velocity to peak mitral annulus velocity. In the multivariable Cox regression analysis, patients with HFPEF showed an increased adjusted HR for cardiac death (2.57; 95% CI, 1.20-5.50), heart failure (HR, 2.25; 95% CI, 1.28-3.96), and fatal or nonfatal cardiovascular event (HR, 2.01; 95% CI, 1.26-3.21) compared with those with no heart failure, but the risk was lower compared with those with HFREF.


      The study included prevalent peritoneal dialysis patients and may introduce survival bias.


      HFPEF is common in peritoneal dialysis patients (∼55% of all heart failure) and is associated with increased risk of mortality and adverse cardiovascular outcomes compared with those with no heart failure, although the risk was lower than in patients with HFREF. This entity needs to be more recognized in peritoneal dialysis patients.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Harnett J.D.
        • Foley R.N.
        • Kent G.M.
        • Barre P.E.
        • Murray D.
        • Parfrey P.S.
        Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.
        Kidney Int. 1995; 47: 884-890
        • Soucie J.M.
        • McClellan W.M.
        Early death in dialysis patients: risk factors and impact on incidence and mortality rates.
        J Am Soc Nephrol. 1996; 7: 2169-2175
        • Wang A.Y.
        • Wang M.
        • Lam C.W.
        • Chan I.H.
        • Lui S.F.
        • Sanderson J.E.
        Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis.
        Clin J Am Soc Nephrol. 2011; 6: 805-812
        • Schiller N.B.
        • Shah P.M.
        • Crawford M.
        • et al.
        Recommendations for quantitation of the left ventricle by two-dimensional echocardiography.
        J Am Soc Echocardiogr. 1989; 2: 358-367
        • Otterstad J.E.
        • Froeland G.
        • St John Sutton M.
        • Holme I.
        Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function.
        Eur Heart J. 1997; 18: 507-513
        • Oki T.
        • Tabata T.
        • Yamada H.
        • et al.
        Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation.
        Am J Cardiol. 1997; 79: 921-928
        • Sohn D.W.
        • Chai I.H.
        • Lee D.J.
        • et al.
        Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function.
        J Am Coll Cardiol. 1997; 30: 474-480
        • Nagueh S.F.
        • Middleton K.J.
        • Kopelen H.A.
        • Zoghbi W.A.
        • Quinones M.A.
        Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures.
        J Am Coll Cardiol. 1997; 30: 1527-1533
        • Nagueh S.F.
        • Appleton C.P.
        • Gillebert T.C.
        • et al.
        Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
        J Am Soc Echocardiogr. 2009; 22: 107-133
        • van Olden R.W.
        • Guchelaar H.J.
        • Struijk D.G.
        • Krediet R.T.
        • Arisz L.
        Acute effects of high-dose furosemide on residual renal function in CAPD patients.
        Perit Dial Int. 2003; 23: 339-347
        • Nolph K.D.
        • Moore H.L.
        • Twardowski Z.J.
        • et al.
        Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis.
        ASAIO J. 1992; 38: M139-M142
        • Myerburg R.J.
        • Castellanos A.
        Cardiac arrest and sudden death.
        in: Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. WB Saunders, Philadelphia, PA1997: 742-779
        • Engelstein E.D.
        • Zipes D.P.
        Sudden cardiac death.
        in: Alexander R.W. Schlant R.C. Fuster V. The Heart, Arteries and Veins. McGraw-Hill, New York, NY1998: 1081-1112
        • Owan T.E.
        • Hodge D.O.
        • Herges R.M.
        • Jacobsen S.J.
        • Roger V.L.
        • Redfield M.M.
        Trends in prevalence and outcome of heart failure with preserved ejection fraction.
        N Engl J Med. 2006; 355: 251-259
        • Hogg K.
        • Swedberg K.
        • McMurray J.
        Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.
        J Am Coll Cardiol. 2004; 43: 317-327
        • Bhatia R.S.
        • Tu J.V.
        • Lee D.S.
        • et al.
        Outcome of heart failure with preserved ejection fraction in a population-based study.
        N Engl J Med. 2006; 355: 260-269
        • Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
        The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: An individual patient data meta-analysis.
        Eur Heart J. 2012; 33: 1750-1757
        • Tripepi G.
        • Benedetto F.A.
        • Mallamaci F.
        • Tripepi R.
        • Malatino L.
        • Zoccali C.
        Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study.
        J Am Soc Nephrol. 2007; 18: 1316-1322
        • Tripepi G.
        • Benedetto F.A.
        • Mallamaci F.
        • Tripepi R.
        • Malatino L.
        • Zoccali C.
        Left atrial volume in end-stage renal disease: a prospective cohort study.
        J Hypertens. 2006; 24: 1173-1180
        • Wang A.Y.
        • Wang M.
        • Lam C.W.
        • Chan I.H.
        • Zhang Y.
        • Sanderson J.E.
        Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease.
        Hypertension. 2008; 52: 107-114
        • Yip G.W.
        • Zhang Y.
        • Tan P.Y.
        • et al.
        Left ventricular long-axis changes in early diastole and systole: impact of systolic function on diastole.
        Clin Sci. 2002; 102: 515-522
        • Zile M.R.
        • Baicu C.F.
        • Gaasch W.H.
        Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle.
        N Engl J Med. 2004; 350: 1953-1959
        • Tan Y.T.
        • Wenzelburger F.
        • Lee E.
        • et al.
        The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion.
        J Am Coll Cardiol. 2009; 54: 36-46
        • Kawaguchi M.
        • Hay I.
        • Fetics B.
        • Kass D.A.
        Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.
        Circulation. 2003; 107: 714-720
        • Edwards N.C.
        • Ferro C.J.
        • Townend J.N.
        • Steeds R.P.
        Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction.
        Heart. 2008; 94: 1038-1043
        • Ooi D.S.
        • Isotalo P.A.
        • Veinot J.P.
        Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology.
        Clin Chem. 2000; 46: 338-344
        • Wang A.Y.
        • Lam C.W.
        • Wang M.
        • et al.
        Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients.
        Clin Chem. 2007; 53: 882-889
        • Wang A.Y.
        • Lam C.W.
        • Yu C.M.
        • et al.
        Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis.
        Kidney Int. 2006; 70: 444-452
        • Khan N.A.
        • Hemmelgarn B.R.
        • Tonelli M.
        • Thompson C.R.
        • Levin A.
        Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis.
        Circulation. 2005; 112: 3088-3096
        • Olivetti G.
        • Abbi R.
        • Quaini F.
        • et al.
        Apoptosis in the failing human heart.
        N Engl J Med. 1997; 336: 1131-1141
        • Goldspink D.F.
        • Burniston J.G.
        • Tan L.B.
        Cardiomyocyte death and the ageing and failing heart.
        Exp Physiol. 2003; 88: 447-458
        • Nadal-Ginard B.
        • Kajstura J.
        • Leri A.
        • Anversa P.
        Myocyte death, growth, and regeneration in cardiac hypertrophy and failure.
        Circ Res. 2003; 92: 139-150
        • Wencker D.
        • Chandra M.
        • Nguyen K.
        • et al.
        A mechanistic role for cardiac myocyte apoptosis in heart failure.
        J Clin Invest. 2003; 111: 1497-1504
        • Amann K.
        • Breitbach M.
        • Ritz E.
        • Mall G.
        Myocyte/capillary mismatch in the heart of uremic patients.
        J Am Soc Nephrol. 1998; 9: 1018-1022
        • Logeart D.
        • Beyne P.
        • Cusson C.T.
        • et al.
        Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain.
        Am Heart J. 2001; 141: 247-253
        • Yasue H.
        • Yoshimura M.
        • Sumida H.
        • et al.
        Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
        Circulation. 1994; 90: 195-203
        • Wang A.Y.
        • Lai K.N.
        Use of cardiac biomarkers in end-stage renal disease.
        J J Am Soc Nephrol. 2008; 19: 1643-1652
        • Wang A.Y.
        • Lam C.W.
        • Yu C.M.
        • et al.
        N-Terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
        J Am Soc Nephrol. 2007; 18: 321-330
        • Kazanegra R.
        • Cheng V.
        • Garcia A.
        • et al.
        A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
        J Card Fail. 2001; 7: 21-29
        • de Boer R.A.
        • Voors A.A.
        • Muntendam P.
        • van Gilst W.H.
        • van Veldhuisen D.J.
        Galectin-3: a novel mediator of heart failure development and progression.
        Eur J Heart Fail. 2009; 11: 811-817
        • McCullough P.A.
        • Olobatoke A.
        • Vanhecke T.E.
        Galectin-3: a novel blood test for the evaluation and management of patients with heart failure.
        Rev Cardiovasc Med. 2011; 12: 200-210
        • Kitzman D.W.
        • Little W.C.
        • Brubaker P.H.
        • et al.
        Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.
        JAMA. 2002; 288: 2144-2150
        • van Heerebeek L.
        • Borbely A.
        • Niessen H.W.
        • et al.
        Myocardial structure and function differ in systolic and diastolic heart failure.
        Circulation. 2006; 113: 1966-1973